NHS Access for Medical Cannabis

What's Currently Available?

Very few Cannabis-Based Medicinal Products are available via NHS prescription, there are currently only a handful of specific conditions with qualified CBPM treatments available. Other more traditional treatments are likely to be explored before the use of CBPMs is considered.

SativexTHC & CBD SprayTreatment for Moderate to Severe Spasticity in Multiple Sclerosis Patients
EpidiolexCBD Isolate OilTreatment for Seizures Associated with Lennox-Gastaut & Dravet Syndromes in Paediatric Patients (with Clobazam)
NabiloneSynthetic THCAdd-on Treatment for Intractable Nausea/Vomiting for Chemotherapy Patients

To the best of our understanding there are currently few prescriptions written for the medicines listed above. Outside of the specific medicines and their relevant use-cases listed, there is currently no further NHS accessibility to CBPMs.

National Health-Service FAQ: Cannabis-Based Medicinal Products
Guidance from National Institute for Health & Care Excellence: Cannabis-Based Medicinal Products.

There is currently a Medical Cannabis Access Bill being debated in parliament which could further CBPM access in the future. If you're currently considering the viability of medical cannabis for your health-care, only private medical clinics may be able to offer access to CBPMs as otherwise listed on this website.

This article was last updated on: 31 July 2022

  Prescription cannabis patients struggling with affordability should be allowed to grow their own, as in Canadian Flag Canada and many American Flag American states. Agree? Sign the Government Petition.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)